Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>Family planning clinicians are adding another choice to the expanding list of long-acting reversible contraceptive options with the September 2016 FDA approval of the Kyleena 19.5 mg levonorgestrel IUD from Whippany, NJ-based Bayer HealthCare Pharmaceuticals. The new IUD is available as of October 2016 by prescription only.</p>

LARC Options Expand With New Intrauterine Device

19.5 mg levonorgestrel Kyleena indicated for use for up to five years